v3.23.1
Certain Balance Sheet Accounts (Tables)
3 Months Ended
Mar. 31, 2023
Certain Balance Sheet Accounts  
Schedule of OMIDRIA contact royalty asset

March 31, 

December 31, 

    

2023

    

2022

(In thousands)

Short-term contract royalty asset

$

28,940

$

28,797

Long-term contract royalty asset

119,681

123,425

Total OMIDRIA contract royalty asset

$

148,621

$

152,222

Schedule of accounts receivable

March 31, 

December 31, 

    

2023

    

2022

(In thousands)

OMIDRIA royalty

$

7,600

$

12,966

Employee retention tax credit

2,131

Sublease and other

302

255

OMIDRIA milestone

 

 

200,000

Total receivables

$

10,033

$

213,221

Property, Plant and Equipment

    

March 31, 

    

December 31, 

2023

2022

(In thousands)

Equipment under finance lease obligations

$

5,977

$

6,204

Laboratory equipment

 

3,164

 

3,135

Computer equipment

 

1,076

 

1,076

Office equipment and furniture

 

625

 

625

Total cost

 

10,842

 

11,040

Less accumulated depreciation and amortization

 

(9,507)

 

(9,548)

Total property and equipment, net

$

1,335

$

1,492

Accrued Expenses

    

March 31, 

    

December 31, 

2023

2022

(In thousands)

Employee compensation

$

8,778

$

6,665

Clinical trials

6,486

5,536

Income taxes payable

4,871

4,871

Interest payable

3,703

5,172

Consulting and professional fees

3,686

4,425

Contract research and development

2,630

3,209

Other accrued expenses

 

667

 

673

Total accrued expenses

$

30,821

$

30,551